BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3499212)

  • 1. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience.
    Wain SL; Braylan RC; Borowitz MJ
    Cancer; 1987 Nov; 60(10):2403-11. PubMed ID: 3499212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
    Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
    Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Cunningham S
    J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.
    Borowitz MJ; Bousvaros A; Brynes RK; Cousar JB; Crissman JD; Whitcomb CC; Kerns BJ; Byrne GE
    Am J Pathol; 1985 Dec; 121(3):514-21. PubMed ID: 2933960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
    Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
    Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA content of T-cell lymphomas. A flow-cytometric analysis.
    Egerter DA; Said JW; Epling S; Lee S
    Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-parameter flow cytometric analysis of an early lymphocyte activation antigen (CK226) and DNA content.
    Zocchi MR; Heltai S; Poggi A
    Cytometry; 1989 Nov; 10(6):762-71. PubMed ID: 2582967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
    Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
    Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
    Armitage JO; Vose JM; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec DF
    J Clin Oncol; 1989 Dec; 7(12):1783-90. PubMed ID: 2585020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
    Smith JL; Jones DB; Bell AJ; Wright DH
    Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic analysis of non-Hodgkin's lymphomas.
    La Via MF; Self SE
    Recenti Prog Med; 1990 Oct; 81(10):629-34. PubMed ID: 2291006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma].
    Chubachi A
    Rinsho Ketsueki; 1989 Dec; 30(12):2134-40. PubMed ID: 2516139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
    Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
    Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.
    Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA
    Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM
    J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of monoclonal antibodies LAU-A1 and anti-Y 29/55 in T and B cell malignancies of children: correlation with immunological markers and clinical data.
    Hirt A; Carrel S; Forster HK; Baumgartner C; Imbach P; Signer E; Wagner HP
    Acta Haematol; 1986; 76(1):9-15. PubMed ID: 3098032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.